Published • loading... • Updated
New Superdrug for Obesity – “in a Class of Its Own”
Summary by Dagens Industri
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Eli Lilly will soon have a new super drug for obesity on the market. “We have never seen such weight reduction before,” says Patrik Jönsson, the Swedish top manager at the American pharmaceutical giant that has outclassed Denmark’s Novo Nordisk. But many Swedes risk missing out on new drugs, he warns.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
